Astec LifeSciences Limited - Laporan Laba Rugi (TTM)

Astec LifeSciences Limited
IN ˙ NSEI
₹ 850.50 ↓ -0.75 (-0.09%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Astec LifeSciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 5,786 5,698 5,587 5,754 5,230 5,803 6,769 7,325 8,297 7,735 6,285 5,871 4,981 4,317 4,586 3,852 3,729 4,160 3,813 4,030
Change (%) -1.53 -1.96 2.99 -9.11 10.97 16.65 8.22 13.27 -6.77 -18.75 -6.59 -15.15 -13.33 6.23 -16.02 -3.18 11.55 -8.34 5.69
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 3,571 3,520 3,457 3,620 3,136 3,314 3,920 4,361 5,076 4,845 4,069 3,870 3,402 3,058 3,249 3,039 3,081 3,343 3,056 2,879
Change (%) -1.44 -1.80 4.73 -13.37 5.66 18.29 11.24 16.39 -4.54 -16.02 -4.88 -12.09 -10.11 6.23 -6.47 1.38 8.53 -8.60 -5.79
% of Revenue 61.72 61.78 61.88 62.92 59.97 57.11 57.91 59.53 61.18 62.64 64.74 65.92 68.30 70.84 70.84 78.89 82.61 80.37 80.14 71.43
Gross Operating Profit 2,215 2,178 2,130 2,133 2,093 2,489 2,849 2,964 3,221 2,890 2,216 2,001 1,579 1,259 1,389 813 649 817 757 1,151
Change (%) -1.67 -2.21 0.17 -1.88 18.91 14.46 4.05 8.67 -10.29 -23.31 -9.72 -21.09 -20.26 10.33 -41.47 -20.23 25.90 -7.27 52.06
% of Revenue 38.28 38.22 38.12 37.08 40.03 42.89 42.09 40.47 38.82 37.36 35.26 34.08 31.70 29.16 30.29 21.11 17.39 19.63 19.86 28.57
SG&A 354 379 394 402 418 447 513 550 586 571 533 557 579 610 629 638 614 625 622 611
Change (%) 7.13 3.88 1.95 4.09 6.85 14.90 7.22 6.47 -2.49 -6.68 4.51 3.98 5.24 3.14 1.35 -3.63 1.77 -0.57 -1.68
% of Revenue 6.12 6.66 7.05 6.98 8.00 7.70 7.58 7.51 7.06 7.39 8.48 9.49 11.63 14.13 13.71 16.55 16.47 15.03 16.30 15.17
R&D
Change (%)
% of Revenue
OpEx 4,754 4,726 4,690 4,895 4,473 4,799 5,566 6,138 6,988 6,731 5,850 5,664 5,151 4,791 5,003 4,760 4,824 5,156 4,912 4,799
Change (%) -0.59 -0.76 4.39 -8.62 7.29 15.97 10.29 13.85 -3.68 -13.08 -3.19 -9.05 -6.99 4.43 -4.86 1.34 6.88 -4.72 -2.31
% of Revenue 82.16 82.93 83.94 85.08 85.54 82.70 82.22 83.80 84.23 87.02 93.09 96.48 103.41 110.97 109.09 123.59 129.36 123.94 128.83 119.08
Operating Income 1,033 973 897 859 756 1,004 1,203 1,187 1,309 1,004 435 207 -170 -474 -416 -909 -1,095 -996 -1,099 -769
Change (%) -5.81 -7.75 -4.29 -11.91 32.72 19.88 -1.36 10.26 -23.29 -56.72 -52.41 -182.26 178.50 -12.20 118.45 20.50 -9.03 10.37 -30.06
% of Revenue 17.84 17.07 16.06 14.92 14.46 17.30 17.78 16.20 15.77 12.98 6.91 3.52 -3.41 -10.97 -9.07 -23.59 -29.36 -23.94 -28.83 -19.08
Interest Expense -72 -49 -43 -43 -48 -63 -87 -111 -140 -173 -202 -227 -242 -244 -249 -254 -288 -326 -363 -403
Change (%) -32.26 -12.61 -0.03 12.31 31.28 38.13 27.54 25.83 23.81 16.69 12.59 6.52 0.90 1.90 2.34 13.13 13.29 11.27 11.03
% of Revenue -1.25 -0.86 -0.76 -0.74 -0.92 -1.08 -1.28 -1.51 -1.68 -2.23 -3.21 -3.87 -4.85 -5.65 -5.42 -6.60 -7.72 -7.84 -9.51 -9.99
Net Income 774 723 650 619 531 708 899 883 975 736 256 60 -258 -509 -469 -785 -1,036 -1,196 -1,348 -1,281
Change (%) -6.60 -9.99 -4.91 -14.19 33.33 26.98 -1.76 10.46 -24.52 -65.27 -76.65 -531.54 97.71 -7.87 67.19 32.03 15.49 12.63 -4.96
% of Revenue 13.37 12.68 11.64 10.75 10.15 12.19 13.28 12.05 11.75 9.52 4.07 1.02 -5.17 -11.80 -10.23 -20.37 -27.78 -28.76 -35.34 -31.78

Source: Capital IQ

Other Listings
IN:533138
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista